期刊文献+

肝纤维化与血管新生研究进展 被引量:6

下载PDF
导出
摘要 肝纤维化(hepatic fibrosis)是继发于各种形式慢性肝损伤之后的组织修复反应,若无有效治疗将演变为肝硬化和肝癌。肝纤维化病理过程中,肝内细胞间以及细胞与基质间发生复杂的相互作用,结缔组织异常增生,引起肝小叶和肝脏血流的病理性改变以及假小叶和结节形成,破坏肝脏实质与功能[1]。肝硬化的早期阶段是可逆,如不及时治疗则可能进展成为失代偿期肝硬化并出现各种终末期肝病并发症[2],肝硬化及其并发症已经成了全球发病与死亡的主要因素,肝纤维化是很多肝病终末期阶段复杂病症发生的基础,如肝腹水、肝门静脉高压、合成功能紊乱、代谢能力受损等。
出处 《肝脏》 2014年第1期65-67,共3页 Chinese Hepatology
  • 相关文献

参考文献27

  • 1Hernandez-Gea V, Friedman S L. Pathogenesis of liver fibrosis. Annu Rev Pathol,2011,6: 425-56.
  • 2Ismail MH, Pinzani M. Reversal of liver fibrosis. Saudi J Gastroenterol, 2009, 15: 72-79.
  • 3Hernandez-Oea V, Friedman SL. Pathogenesis of liver fibrosis. AnnuRev Pathol 2011: 6:425-456.
  • 4IPMID: 21073339 DOI: 10. 1146/annurevpathol-011110-130246.
  • 5Valfre di Bonzo L,Novo E,Cannito S,et al. Angiogenesis and liver fibrogenesis. Histol Histopathol,2009, 24: 1323-1341.
  • 6Fraisl P,Mazzone M, Schmidt T, et al. Regulation of angiogenesis by oxygen and metabolism. Dev Cell,2009, 16: 167-179.
  • 7Salcedo X, Medina J, Sanz Cameno P, et al. The potential of angiogenesis soluble markers in chronic hepatitis C. Hepatology, 2005,42 : 696-701.
  • 8DeLEVE LD. Hepatic mierovasculature in liver injury. Semin Liver Dis, 2007, 27: 390-400.
  • 9Lemos QT, Andrade ZA. Angiogenesis and experimental hepatic fibrosis. Mem Inst Oswaldo Cruz, 2010, 105: 611-614.
  • 10吕靖,陆雄,陶艳艳,赵志敏,刘成海.肝纤维化小鼠肝组织血管新生特点及其形成机制[J].肝脏,2011,16(1):35-40. 被引量:13

二级参考文献66

  • 1涂传涛,郭津生,方国汀,王吉耀.环氧合酶-2在CCl_4诱导大鼠肝纤维化形成中的作用[J].复旦学报(医学版),2006,33(5):587-591. 被引量:5
  • 2Medina J, Arroyo AG, Sanchez-Madrid F, et al. Angiogenesis in chronic inflammatory liver disease [ J ]. Hepatology, 2004, 39 (5) : 1185- 1195.
  • 3Carmeliet P. Angiogenesis in health and disease [J]. Nat Med, 2003, 9(6) : 653-660.
  • 4Medina J, Sanz-Cameno P, Garcla-Buey L, et al. Evidence of anglogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study [J]. J Hepatol, 2005, 42(1): 124-131.
  • 5Corpechot C, Barbu V, Wendum D, et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis [ J ]. Hepatology, 2002, 35 (5) : 1010-1021.
  • 6Iniguez MA, Rodriguez A, Volpert OV, et al. Cyclooxygenase-2: a therapeutic target in angiogenesis [ J]. Trends Mol Med, 2003, 9(2) : 73 -78.
  • 7Olenyuk B, Zhang GJ, Klco JM, et al. Inhibitor of vascular endothelial growth factor with a sequence-specific bypoxia response element antagonist [J]. PNAS, 2004, 100(48): 16768-16773.
  • 8Chen Y, Abraham D J, Shi-Wen X, et al. CCN2 ( connective tissue growth factor) promotes fibroblast adhesion to fibronectin [ J]. Mol Biol Cell, 2004, 15(12) : 5635-5646.
  • 9Fort J, Pilette C, Oberti F, et al. Long-term administration of PGEl increases liver fibrosis and collateral blood flow in bile-duct-ligated rats [J]. J Hepatol, 1999, 30(1):70-/6.
  • 10E1-Assal ON, Yamanoi A, Soda Y, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver [J]. Hepatology, 1998, 27(6): 1554-1562.

共引文献90

同被引文献52

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部